HeyVoli

Infrastructure for Connected Healthcare Systems, unifying fragmented data and enabling interoperability.

Cover Block

From the public record

Field	Value
Company	HeyVoli
Tagline	Infrastructure for Connected Healthcare Systems, unifying fragmented data and enabling interoperability [heyvoli.com, retrieved 2026]
Headquarters	Bengaluru, India [LinkedIn, retrieved 2026]
Founded	2023 [LinkedIn, retrieved 2026]
Stage	Pre-Seed [TheSaaSNews, October 2026]
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	South Asia
Growth Profile	Venture Scale
Founding Team	Akansha Jalan, Venkatesh Prasad G [TheSaaSNews, October 2026] [GetLatka, October 2026]
Funding Label	Pre-seed [TheSaaSNews, October 2026]
Total Disclosed	~$500,000 [TheSaaSNews, October 2026]

The Short Version

PUBLIC HeyVoli is building software infrastructure for connected healthcare systems, and it merits investor attention now because the company has recently repositioned into healthcare interoperability and closed a $500,000 pre-seed round to fund product development and pilots [heyvoli.com, September 2026] [TheSaaSNews, October 2026]. Public records place the company in Bengaluru and indicate a 2023 founding date, but the more relevant near-term fact is the September 2026 pivot from a generative AI content product toward healthcare data, workflow, and intelligence infrastructure, which materially changes how the business should be underwritten [LinkedIn, retrieved 2026] [heyvoli.com, September 2026] [GetLatka, October 2026].

The product thesis, based largely on company materials, is an interoperability and intelligence layer that sits alongside existing healthcare systems rather than replacing them, with modules spanning CareOS, FlowGrid, SignalNet, TwinMind, CoreK, and Population Health [heyvoli.com, retrieved 2026]. That positioning is credible in concept because healthcare IT buyers often need integration before full system replacement, and HeyVoli says its architecture is aligned with ABDM and FHIR-native standards, although those technical claims remain company-sourced at this stage [heyvoli.com, retrieved 2026].

Founder visibility is still limited. Akansha Jalan is identified as a founder in funding coverage, while Venkatesh Prasad G is listed as founder or CEO in public profile data; LinkedIn signals product and design-oriented backgrounds, which fits an early product buildout, but the public record does not yet establish a deep bench in healthcare enterprise sales or large-scale provider deployments [TheSaaSNews, October 2026] [GetLatka, October 2026] [LinkedIn, retrieved 2026].

On capitalization, the only confirmed round is the October 2026 pre-seed of $500,000, with no named investors surfaced in the available reporting; the business model is described as SaaS, and management has said the proceeds will support development of the AI-powered platform and pilot programs [TheSaaSNews, October 2026] [Oneindia, October 2026]. Over the next 12 to 18 months, the key questions are straightforward: whether HeyVoli can convert broad platform language into named pilots, referenceable integrations, and repeatable healthcare workflows, and whether the post-pivot narrative settles into a consistent company identity across public records [heyvoli.com, September 2026] [TheSaaSNews, October 2026] [LinkedIn, retrieved 2026].

Unconfirmed -- This section relies materially on company materials for product scope and pivot history, with partial corroboration from TheSaaSNews, Oneindia, LinkedIn, and GetLatka.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	South Asia
Growth Profile	Venture Scale
Funding	Pre-seed, total disclosed ~$500,000

The Company in Brief

PUBLIC HeyVoli presents as a Bengaluru-based healthtech startup, but the cleaner way to read the public record is as a company that has only recently settled on its current identity. Its website now describes the business as "Infrastructure for Connected Healthcare Systems," with a platform intended to unify patient records, clinical workflows, medical data, and real-time intelligence across healthcare settings [heyvoli.com, retrieved 2026]. The company’s LinkedIn profile lists it as founded in 2023 and based in Bengaluru, India, which aligns at a high level with the current website footprint, though the website itself does not surface a legal entity name in the materials reviewed here [LinkedIn, retrieved 2026].

The key public milestone is the September 2026 repositioning from a generative-AI product toward healthcare infrastructure. In its own announcement, HeyVoli said it was entering its "next chapter" with an interoperability layer designed to work alongside existing healthcare systems rather than replace them [heyvoli.com, September 2026]. One month later, TheSaaSNews reported a $500,000 pre-seed round for the company to develop its AI-powered healthcare platform and begin pilot programs, giving the first clear outside timestamp for the current strategy [TheSaaSNews, October 2026].

Single-source, plausible -- Founding year and headquarters are corroborated by LinkedIn and the company website at a general level, but the section relies materially on company statements for the September 2026 strategic pivot and no legal entity filing was confirmed in the cited sources.

What They Have Built

Mixed sourcing The product story is interesting because the company is not presenting as a point solution. HeyVoli describes itself as building "Infrastructure for Connected Healthcare Systems," with an interoperability and intelligence layer intended to sit alongside existing healthcare software rather than replace it outright [heyvoli.com, retrieved 2026] [heyvoli.com, September 2026]. On the public website, that layer is framed around unifying patient records, clinical workflows, medical data, and real-time operational signals, with stated alignment to FHIR-native standards and India’s Ayushman Bharat Digital Mission architecture [heyvoli.com, retrieved 2026].

The named product surfaces suggest a broad platform ambition, although the evidence remains almost entirely company-provided. HeyVoli lists CareOS, FlowGrid, SignalNet, TwinMind, CoreK, and Population Health among its solutions, and describes capabilities spanning healthcare data interoperability, digital twins, AI orchestration, IoT and real-time intelligence, and supply-chain intelligence [heyvoli.com, retrieved 2026]. More specifically, the company says CareOS coordinates clinical workflows, scheduling, and administrative operations, while FlowGrid "turns events into coordinated workflows" for multidisciplinary teams [HeyVoli, retrieved 2026]. Its population-health materials describe a continuously updated view built from longitudinal data, real-time events, population insights, and AI, but no verified public demo, deployment detail, or technical documentation in the sourced materials establishes how much of that stack is already in production versus positioned as platform architecture [heyvoli.com, retrieved 2026].

The main analytical point is that the product surface is wide relative to the public proof points. The September 2026 pivot materials show a clear repositioning from an earlier generative-AI orientation toward healthcare infrastructure, and public coverage of the October 2026 pre-seed ties that repositioning to planned platform development and pilot programs rather than already documented scaled rollouts [heyvoli.com, September 2026] [GetLatka, October 2026] [TheSaaSNews, October 2026] [Oneindia, October 2026]. That does not invalidate the architecture claim, but it does mean investors should read the current stack primarily as company-stated product intent with limited third-party verification.

Unconfirmed -- This section relies primarily on company website and company-linked materials, with limited independent corroboration from funding coverage.

Market Size and Demand

PUBLIC The market matters now because healthcare data plumbing is moving from a back-office IT problem to a policy and operating constraint, particularly in systems that want to coordinate care across clinics, hospitals, labs, payers, and public-health programs [heyvoli.com, September 2026] [Free Press Release, September 2026].

HeyVoli is positioning into healthcare interoperability and workflow infrastructure rather than a narrowly defined software niche, which makes precise TAM work difficult from the public record. No third-party market-sizing report was provided in the available source set, so any market framing has to stay qualitative. The closest public description of demand comes from the company and announcement coverage: fragmented patient records, disconnected workflows, and the need to work alongside existing systems are presented as the core pain points for hospitals, laboratories, pharmacies, insurers, clinics, and public-health organizations [heyvoli.com, retrieved 2026] [heyvoli.com, September 2026] [TheSaaSNews, October 2026].

That framing points to an addressable market that sits across several adjacent budgets: clinical systems integration, healthcare workflow software, population-health data infrastructure, and real-time operational intelligence. In practice, this is less a single market than a spending overlap among providers and public-health operators that need interoperability, event-driven coordination, and analytics on top of legacy systems [heyvoli.com, retrieved 2026] [HeyVoli, retrieved 2026]. Because the sources do not provide third-party revenue benchmarks or procurement data, the more defensible reading is that HeyVoli is chasing a broad systems-enablement layer whose eventual scope will depend on where pilots convert first, not a fully evidenced market wedge today [TheSaaSNews, October 2026].

Demand drivers in the public record are clearer than market size. HeyVoli's own materials repeatedly anchor on unifying records, workflows, and real-time intelligence, and say the architecture is aligned with India's Ayushman Bharat Digital Mission and FHIR-native standards [heyvoli.com, retrieved 2026]. If that alignment is real in deployment terms, the tailwind is straightforward: policy and buyer preference increasingly favor software that can interoperate with existing digital-health stacks rather than replace them wholesale [heyvoli.com, September 2026]. The other visible tailwind is operational, not regulatory. A platform that can turn events into coordinated workflows, which is how the company describes FlowGrid, is speaking to staffing pressure and coordination complexity inside care delivery settings [HeyVoli, retrieved 2026].

The substitute set is broad, and that matters for market entry. A hospital or clinic could address the same problem through incumbent hospital information systems, point integrations between record systems and labs, standalone workflow tools, public-health reporting systems, or internal services work that stitches existing software together. HeyVoli's opportunity, according to its own positioning, rests on being the interoperability and intelligence layer across those fragmented tools rather than the system of record itself [heyvoli.com, September 2026] [heyvoli.com, retrieved 2026]. That is strategically sensible on paper, but it also means the company is entering a market where buyers may compare it against internal build paths and incumbent vendor modules, not just other startups.

The macro and regulatory backdrop is supportive in principle, but the evidence remains company-led. The strongest public signal is HeyVoli's explicit alignment with ABDM and FHIR-native standards, which suggests management sees standards-based interoperability as a route into Indian healthcare digitization rather than an optional feature [heyvoli.com, retrieved 2026]. The caution is that no public source here documents completed deployments, named integration partners, or customer references that would show this demand has already translated into procurement momentum [TheSaaSNews, October 2026] [LinkedIn, retrieved 2026]. At this stage, the market case is plausible, especially in India where connected care infrastructure is still being built out, but public proof of near-term capture is thin.

Market lens	Public evidence	Source quality
Core problem area	Fragmented patient records, workflows, and medical data across healthcare settings	Company description, repeated across site materials [heyvoli.com, retrieved 2026]
Buyer universe	Clinics, hospitals, laboratories, pharmacies, insurers, and public-health organizations	Company announcement and funding coverage [heyvoli.com, September 2026] [TheSaaSNews, October 2026]
Standards tailwind	ABDM alignment and FHIR-native architecture	Company claim only [heyvoli.com, retrieved 2026]
Near-term commercialization signal	Planned pilot programs after pre-seed financing	Independent coverage, but no named sites [TheSaaSNews, October 2026]

The table makes the key point: the problem definition and buyer map are visible, but the strongest market-tailwind claims still trace back to the company rather than to independent market research or adoption data. For investors, that keeps the market question open less on whether the need exists and more on whether this team can convert a broad infrastructure thesis into a narrow, repeatable first use case.

Unconfirmed -- This section relies primarily on company materials for market definition and demand drivers, with limited independent corroboration from funding coverage and no third-party market-sizing report in the provided sources.

Who Else Is Fighting for This

Competitive map

MIXED The company is positioning itself less as a replacement electronic health record and more as a connective layer for fragmented healthcare software, which puts it in practical competition with incumbent hospital systems, interoperability vendors, and in-house integration efforts rather than with a single clearly disclosed startup peer [heyvoli.com, retrieved 2026] [heyvoli.com, September 2026].

The public record is thin on named rivals, but the category boundaries are still visible. On the incumbent side, HeyVoli says it works alongside existing healthcare systems, which implies coexistence with hospital information systems, lab software, pharmacy systems, insurer workflows, and public-health databases already in use across India and similar markets [heyvoli.com, September 2026]. On the challenger side, its own product language spans interoperability, workflow orchestration, population health, digital twins, and real-time intelligence, a breadth that suggests overlap with multiple software categories at once rather than a narrow single-product entry point [heyvoli.com, retrieved 2026]. The adjacent substitute is simpler and often harder to displace than software competition: internal IT teams stitching together APIs, exports, and manual workflows inside provider networks.

That breadth cuts both ways. It gives HeyVoli a larger theoretical addressable surface, because a hospital group or public-health operator may prefer one coordination layer over several point tools if integration and workflow logic sit in the same stack [heyvoli.com, retrieved 2026]. But it also means the company may encounter different buying motions in each segment, with clinical operations, IT, compliance, and public-sector stakeholders likely evaluating the platform through different criteria, none of which are yet validated by named deployments or customer references in public sources [TheSaaSNews, October 2026].

The clearest edge visible today is regulatory and architectural positioning, not distribution. HeyVoli says its architecture is aligned with India's Ayushman Bharat Digital Mission and uses FHIR-native data standards, and if that is implemented in production it would matter because interoperability products tend to win or lose on standards compliance and fit with existing systems rather than on interface design alone [heyvoli.com, retrieved 2026]. The problem is durability. Those claims come from company materials, while public evidence of customers, integrations, or ecosystem partnerships is absent, so any edge still appears perishable until third parties confirm that the stack works under live healthcare workloads [TheSaaSNews, October 2026] [Oneindia, October 2026].

Exposure is easier to identify than advantage. The company raised a reported $500,000 pre-seed in October 2026, has a LinkedIn headcount band of 1 to 10 employees, and appears to have pivoted from a generative-AI content product to healthcare infrastructure in September 2026, leaving little public evidence yet of specialized go-to-market muscle, referenceability, or implementation depth against entrenched vendors and health-system procurement cycles [TheSaaSNews, October 2026] [LinkedIn, retrieved 2026] [heyvoli.com, September 2026] [GetLatka, October 2026]. A hospital CIO comparing vendors may accept a new interoperability layer, but would still weigh execution risk against established internal systems or better-capitalized infrastructure providers. The adjacent substitute of doing less, or integrating just enough with internal resources, may be the near-term competitor that matters most.

Over the next 18 months, the most plausible scenario is not category dominance but a proof-of-fit race. HeyVoli is the likely winner if ABDM-aligned interoperability becomes a practical procurement filter and the company can convert its stated pilot plans into a small number of referenceable deployments before broader platform claims outpace execution [heyvoli.com, retrieved 2026] [TheSaaSNews, October 2026]. HeyVoli is also the likely loser if the product remains a wide platform narrative without named implementations, because in that case incumbent software estates and internal integration teams retain the advantage by default, particularly in settings where buyers prefer incremental workflow fixes over a new orchestration layer.

Unconfirmed -- Competitive positioning relies primarily on company statements, with partial public corroboration on funding, headcount band, and pivot timing from TheSaaSNews, LinkedIn, and GetLatka.

Opportunity

From the public record If HeyVoli executes on the thesis it now presents, the prize is not a point solution sale but a position in the control layer that sits between fragmented Indian healthcare systems and the workflows that increasingly need interoperable, machine-readable data [heyvoli.com, retrieved 2026] [heyvoli.com, September 2026].

The clearest upside case is that HeyVoli becomes a lightweight interoperability and workflow orchestration layer for care providers, labs, pharmacies, insurers, and public-health operators that do not want to replace existing systems but do need those systems to exchange data and trigger coordinated actions [heyvoli.com, September 2026] [Free Press Release, September 2026]. That outcome is still early and largely company-described, but it is not purely aspirational. The company has narrowed its positioning around connected healthcare infrastructure, says its architecture is aligned with ABDM and FHIR-native standards, and raised a disclosed $500,000 pre-seed to build the platform and start pilots, which at least establishes some external capital formation behind the pivot [heyvoli.com, retrieved 2026] [TheSaaSNews, October 2026] [Oneindia, October 2026]. In plain terms, the reachable version of success is not "build everything in healthcare," but "become the coordination fabric that existing healthcare software can plug into."

The paths to scale are easier to see when broken into a few concrete routes.

Scenario	What happens	Catalyst	Why it's plausible
ABDM-aligned middleware layer	HeyVoli becomes the integration and workflow layer used by providers and adjacent healthcare operators that need data interoperability without replacing core systems	Successful pilots after the October 2026 pre-seed, especially if they demonstrate that ABDM- and FHIR-aligned data exchange can be deployed with low workflow disruption [TheSaaSNews, October 2026] [heyvoli.com, retrieved 2026]	The company is explicitly positioning around interoperability, existing-system coexistence, and standards alignment rather than full system replacement [heyvoli.com, September 2026] [Free Press Release, September 2026]
Population-health intelligence stack	The company uses its population-health layer to sell into public-health and system-level use cases where longitudinal records and real-time events matter more than single-site workflow tools	A credible deployment or pilot showing that its population-health product can combine longitudinal data, events, and AI into a continuously updated operational view [heyvoli.com, retrieved 2026] [TheSaaSNews, October 2026]	The public product language already extends beyond workflow automation into system-wide intelligence, which is strategically broader if the data layer is real and usable [heyvoli.com, retrieved 2026]
Multi-product operating system for care delivery	CareOS, FlowGrid, SignalNet, TwinMind, CoreK, and Population Health become a bundled stack that increases switching costs once one module is adopted [heyvoli.com, retrieved 2026]	One early module wins a foothold, then adjacent modules expand account scope through the same integration footprint [HeyVoli, retrieved 2026] [heyvoli.com, retrieved 2026]	The company is already presenting a family of products rather than a single feature, and FlowGrid and CareOS are described as workflow and operations layers that could naturally sit near the center of daily usage [HeyVoli, retrieved 2026]

What would make the model compound is the combination of integration depth and workflow adjacency. If HeyVoli can connect records, operational events, and administrative workflows inside one customer environment, each deployment should make the next module easier to sell because the hard part, integration and data normalization, has already been paid for once [heyvoli.com, retrieved 2026] [HeyVoli, retrieved 2026]. That is the attractive shape of the business. The same installed data layer could support workflow automation through FlowGrid, operating coordination through CareOS, and eventually higher-value intelligence products such as population health or digital twin applications, all described on the company site [heyvoli.com, retrieved 2026]. The public evidence does not yet show named customers or completed deployments, so the flywheel is still a thesis rather than an observed fact, but the product architecture the company describes is one where attachment rates could matter more than initial logo count if pilots convert [TheSaaSNews, October 2026] [heyvoli.com, retrieved 2026].

The size of the win is best framed conditionally because no verified market-sizing figure or direct public comparable appears in the source set. In the strongest version of the first scenario, HeyVoli could become an acquisition target for a larger healthtech or enterprise software company that wants ABDM-aligned interoperability and workflow infrastructure in India, especially if it proves it can sit across multiple care settings [heyvoli.com, September 2026] [TheSaaSNews, October 2026]. In the strongest version of the second or third scenario, it could mature into an independent infrastructure software company with multiple products on a shared data backbone. That would support a venture-scale outcome (scenario, not a forecast), but the present public record is too thin on customers, revenue, and deployments to anchor a defensible value range without inventing precision. The upside is real because infrastructure layers can become central once embedded; the uncertainty is equally real because HeyVoli still has to prove that the September 2026 pivot can turn product language into repeatable implementation motion [heyvoli.com, September 2026] [GetLatka, October 2026].

Unconfirmed -- This section relies materially on company-described product positioning and architecture, with limited independent corroboration beyond the October 2026 funding coverage from TheSaaSNews and Oneindia.

Sources